Different pathologic responses to neoadjuvant anti-PD-1 in primary squamous lung cancer and regional lymph nodes

Neoadjuvant immunotherapy provides a unique opportunity for understanding therapeutic responses. We analyzed pathologic responses in surgical specimens obtained from 31 squamous non-small cell lung cancer (NSCLC) patients receiving neoadjuvant anti-PD-1 treatment. Fifteen (48.4%) patients achieved p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ling, Yun, Li, Ning, Li, Lin, Guo, Changyuan, Wei, Jiacong, Yuan, Pei, Tan, Fengwei, Tao, Xiuli, Wang, Shuhang, Wang, Zhijie, Wu, Ning, Wang, Jie, Ying, Jianming, Gao, Shugeng, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708412/
https://www.ncbi.nlm.nih.gov/pubmed/33299121
http://dx.doi.org/10.1038/s41698-020-00135-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708412/
https://www.ncbi.nlm.nih.gov/pubmed/33299121
http://dx.doi.org/10.1038/s41698-020-00135-2

Ejemplares similares